Thorax

Global perspective on pulmonary fibrosis: epidemiology, regional variations, gaps in care and future directions

Background Pulmonary fibrosis (PF) caused by interstitial lung diseases (ILDs) affects up to 0.1% of the global population. There is growing global interest in PF, evident from a nearly threefold ...
thorax.bmj

Development and validation of the Hypersensitivity Pneumonitis South Asian Questionnaire for Exposure (HP-SAQE): a novel, qualitative and quantitative tool

Introduction There is an unmet need for a validated qualitative and quantitative tool to assess environmental exposures in patients with interstitial lung disease (ILD). This study aimed to develop ...
thorax.bmj

Effects of inhaled salbutamol in exercising non-asthmatic athletes

BACKGROUND Beta-2 agonists such as salbutamol are used, not only by asthmatic athletes to prevent exercise induced asthma, but also by non-asthmatic athletes as a potentially ergogenic agent. We have ...
thorax.bmj

Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment

Dr E Hnizdo, National Institute for Occupational Safety and Health, 1095 Willowdale Road, MS PB 163, Morgantown, WV 26505, USA BACKGROUND A study was undertaken to establish the chronic effect of ...
thorax.bmj

The short-term association between asthma hospitalisations, ambient temperature, other meteorological factors and air pollutants in Hong Kong: a time-series study

1 The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong SAR Correspondence to William B Goggins III, The Jockey Club School of Public Health ...
thorax.bmj

Community-based evaluation of immigrant tuberculosis screening using interferon γ release assays and tuberculin skin testing: observational study and economic analysis

1 Department of Respiratory Medicine, Tuberculosis Research Unit, National Heart and Lung Institute, Imperial College London, London, UK 2 Department of Infectious Disease Epidemiology, MRC Centre for ...
thorax.bmj

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

5 Division of Respiratory Medicine, Nottingham City Hospital, Nottingham NG5 1PB, UK Correspondence to: Dr J T Macfarlane, Respiratory Infection Research Group, Respiratory Medicine, Nottingham City ...
thorax.bmj

P120 Evaluating the use of the NEWS2 SpO2 Scales in COPD patients admitted to medical wards: a prospective clinical audit

Objective NEWS2 (RCP 2017) 1 recommends use of ‘SpO2 Scale 2’ in patients with hypercapnic respiratory failure (usually due to COPD) to aim target saturations of 88–92%. We aimed to identify if COPD ...
thorax.bmj

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease

a Academic Department of Respiratory Medicine, St Bartholomew’s and Royal London School of Medicine and Dentistry, London Chest Hospital, London, UK, b Division of Physiological Medicine, St George’s ...
thorax.bmj

Effect of mindfulness training on asthma quality of life and lung function: a randomised controlled trial

1 Division of Preventive and Behavioral Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA 2 Division of Pulmonary, Allergy and Critical Care Medicine, University of ...
thorax.bmj

Historic air pollution exposure and long-term mortality risks in England and Wales: prospective longitudinal cohort study

Correspondence to Dr Anna Hansell, UK Small Area Health Statistics Unit, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London W2 1PG, UK; ...
thorax.bmj

COVID-19 public health measures: a reduction in hospital admissions for COPD exacerbations

Hospitalisations for acute exacerbations of COPD (AECOPD) carry significant morbidity and mortality. Respiratory viral infections (RVIs) are the most common cause of AECOPD and are associated with ...